CSL Future Growth
Future criteria checks 2/6
CSL is forecast to grow earnings and revenue by 13% and 6.5% per annum respectively. EPS is expected to grow by 13% per annum. Return on equity is forecast to be 18.5% in 3 years.
Key information
13.0%
Earnings growth rate
13.0%
EPS growth rate
Biotechs earnings growth | 42.4% |
Revenue growth rate | 6.5% |
Future return on equity | 18.5% |
Analyst coverage | Good |
Last updated | 25 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2027 | 18,034 | 4,131 | 4,113 | 4,966 | 14 |
6/30/2026 | 16,899 | 3,627 | 3,588 | 4,369 | 15 |
6/30/2025 | 15,770 | 3,096 | 2,966 | 3,792 | 15 |
6/30/2024 | 14,800 | 2,642 | 1,506 | 2,764 | N/A |
3/31/2024 | 14,490 | 2,557 | 1,332 | 2,727 | N/A |
12/31/2023 | 14,179 | 2,472 | 1,158 | 2,690 | N/A |
9/30/2023 | 13,745 | 2,333 | 1,034 | 2,646 | N/A |
6/30/2023 | 13,310 | 2,194 | 909 | 2,601 | N/A |
3/31/2023 | 12,507 | 2,156 | 765 | 2,392 | N/A |
12/31/2022 | 11,705 | 2,118 | 622 | 2,182 | N/A |
9/30/2022 | 11,133 | 2,186 | 1,001 | 2,406 | N/A |
6/30/2022 | 10,562 | 2,255 | 1,381 | 2,629 | N/A |
3/31/2022 | 10,587 | 2,290 | 1,251 | 2,679 | N/A |
12/31/2021 | 10,612 | 2,325 | 1,121 | 2,728 | N/A |
9/30/2021 | 10,461 | 2,350 | 1,538 | 3,175 | N/A |
6/30/2021 | 10,310 | 2,375 | 1,955 | 3,622 | N/A |
3/31/2021 | 10,145 | 2,520 | 2,127 | 3,597 | N/A |
12/31/2020 | 9,980 | 2,665 | 2,299 | 3,571 | N/A |
9/30/2020 | 9,565 | 2,384 | 1,710 | 3,030 | N/A |
6/30/2020 | 9,151 | 2,103 | 1,121 | 2,488 | N/A |
3/31/2020 | 9,048 | 2,054 | 1,009 | 2,418 | N/A |
12/31/2019 | 8,944 | 2,006 | 897 | 2,347 | N/A |
9/30/2019 | 8,742 | 1,962 | 628 | 1,996 | N/A |
6/30/2019 | 8,539 | 1,919 | 360 | 1,644 | N/A |
3/31/2019 | 8,406 | 1,861 | 426 | 1,621 | N/A |
12/31/2018 | 8,274 | 1,803 | 492 | 1,597 | N/A |
9/30/2018 | 8,094 | 1,766 | 701 | 1,750 | N/A |
6/30/2018 | 7,915 | 1,729 | 910 | 1,902 | N/A |
3/31/2018 | 7,666 | 1,674 | N/A | 1,662 | N/A |
12/31/2017 | 7,417 | 1,618 | N/A | 1,422 | N/A |
9/30/2017 | 7,182 | 1,478 | N/A | 1,335 | N/A |
6/30/2017 | 6,947 | 1,337 | N/A | 1,247 | N/A |
3/31/2017 | 6,802 | 1,333 | N/A | 1,192 | N/A |
12/31/2016 | 6,656 | 1,329 | N/A | 1,138 | N/A |
9/30/2016 | 6,386 | 1,286 | N/A | 1,158 | N/A |
6/30/2016 | 6,115 | 1,242 | N/A | 1,179 | N/A |
3/31/2016 | 5,983 | 1,324 | N/A | 1,296 | N/A |
12/31/2015 | 5,850 | 1,406 | N/A | 1,413 | N/A |
9/30/2015 | 5,654 | 1,392 | N/A | 1,388 | N/A |
6/30/2015 | 5,459 | 1,379 | N/A | 1,364 | N/A |
3/31/2015 | 5,482 | 1,366 | N/A | 1,434 | N/A |
12/31/2014 | 5,505 | 1,354 | N/A | 1,504 | N/A |
9/30/2014 | 5,420 | 1,330 | N/A | 1,432 | N/A |
6/30/2014 | 5,335 | 1,307 | N/A | 1,361 | N/A |
3/31/2014 | 5,189 | 1,270 | N/A | 1,257 | N/A |
12/31/2013 | 5,042 | 1,233 | N/A | 1,154 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CSJA's forecast earnings growth (13% per year) is above the savings rate (1%).
Earnings vs Market: CSJA's earnings (13% per year) are forecast to grow slower than the German market (20.9% per year).
High Growth Earnings: CSJA's earnings are forecast to grow, but not significantly.
Revenue vs Market: CSJA's revenue (6.5% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: CSJA's revenue (6.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CSJA's Return on Equity is forecast to be low in 3 years time (18.5%).